KRUSZEWSKA DANUTA has a total of 15 patent applications. Its first patent ever was published in 2003. It filed its patents most often in Republic of Korea, China and EPO (European Patent Office). Its main competitors in its focus markets pharmaceuticals, foods and drinks and biotechnology are REGENTEC LTD, ZHAO JONATHON Z and AMULET PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Republic of Korea | 3 | |
#2 | China | 2 | |
#3 | EPO (European Patent Office) | 2 | |
#4 | Poland | 2 | |
#5 | United States | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | India | 1 | |
#8 | Sweden | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Foods and drinks | |
#3 | Biotechnology | |
#4 | Medical technology | |
#5 | Civil engineering |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Foods | |
#4 | Microorganisms | |
#5 | Object sterilising | |
#6 | Fodder | |
#7 | Fire-fighting | |
#8 | Microorganisms |
# | Name | Total Patents |
---|---|---|
#1 | Kruszewska Danuta | 15 |
#2 | Pierzynowski Stefan | 1 |
Publication | Filing date | Title |
---|---|---|
EP2674162A1 | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same | |
WO2013180585A1 | Nanoproduct comprising lactobacillus reuteri dan080 useful in prophylaxis and medicine, both human and veterinary and medical use of the same | |
PL386978A1 | The manner of increase of efficiency of ecological biomass processing and biological preparation for activation of digestome bioreactor | |
WO2009005379A1 | New medical applications of alpha-ketoglutarate | |
PL380103A1 | Agent for preventing and/or inhibiting the colonization of Helicobater pylori and its application |